S
Sutro Biopharma D
D
STRO
3.76000
USD
-0.21
(-5.29%)
مفتوح الان
حجم التداول
1,691
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
312,281,541
العنوان: Sutro Biopharma
القطاع: Healthcare
الصناعة: Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancerand autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.